Company / EPS (Diluted)
Avanos Medical, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.32
FY2025
5-year range
-$1.32 / $1.07
FY2021-FY2025
Trend
-223.4%
vs FY2024
Sector context
#128 of 159
Health Care
What the data says
EPS (Diluted) changed -223% YoY in FY2025, a notable deviation from the 9-year average annual change of -113%.
Based on SEC 10-K filings.
-1.32 in FY2025.
Declined from $0.13 to $-1.32 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 159This company -$1.32 Sector average $1.66
▼
-179.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 223.4% year-over-year.
- Ranks #128 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.32 | -223.4% |
| FY2024 | $1.07 | +723.1% |
| FY2023 | $0.13 | +121.3% |
| FY2022 | -$0.61 | +36.5% |
| FY2021 | -$0.96 | -178.7% |
| FY2020 | $1.22 | -27.8% |
| FY2019 | $1.69 | +98.8% |
| FY2018 | $0.85 | +109.3% |
| FY2017 | -$9.15 | -1677.6% |
| FY2016 | $0.58 | -82.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026